Lotus Bio-Technology Development (Lotus Bio-Technology Development) EV-to-EBITDA : -903.23 (As of Jun. 02, 2024)

Lotus Bio-Technology Development EV-to-EBITDA Chart

Lotus Bio-Technology Development Quarterly Data
	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17
EV-to-EBITDA	Get a 7-Day Free Trial															-147.78	-14.95	-	-	-20.24

Competitive Comparison of Lotus Bio-Technology Development's EV-to-EBITDA

For the Agricultural Inputs subindustry, Lotus Bio-Technology Development's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lotus Bio-Technology Development's EV-to-EBITDA Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Lotus Bio-Technology Development's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Lotus Bio-Technology Development's EV-to-EBITDA falls into.

Lotus Bio-Technology Development EV-to-EBITDA Calculation

Lotus Bio-Technology Development's EV-to-EBITDA for today is calculated as:

Lotus Bio-Technology Development's current Enterprise Value is $11.74 Mil.
Lotus Bio-Technology Development's EBITDA for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development  (OTCPK:LBTD) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Lotus Bio-Technology Development's PE Ratio for today is calculated as:

Lotus Bio-Technology Development's share price for today is $0.01.
Lotus Bio-Technology Development's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Lotus Bio-Technology Development EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Lotus Bio-Technology Development's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Lotus Bio-Technology Development (Lotus Bio-Technology Development) Business Description